{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:15:53Z","timestamp":1793718953378,"version":"4.6.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11133-7","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:33:33Z","timestamp":1761032013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mesenchymal stem cell therapy for type 2 diabetes: mechanisms, clinical evidence, and future directions"],"prefix":"10.1007","volume":"52","author":[{"given":"Malek","family":"Zarei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"3","key":"11133_CR1","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.2004","volume":"7","author":"MJ Hossain","year":"2024","unstructured":"Hossain MJ, Al-Mamun M, Islam MR (2024) Diabetes mellitus, the fastest growing global public health concern: early detection should be focused. Health Sci Rep 7(3):e2004","journal-title":"Health Sci Rep"},{"key":"11133_CR2","doi-asserted-by":"crossref","unstructured":"Zarei M, Sahebi Vaighan N, Farjoo MH, Talebi S, Zarei M (2024) Incretin-based therapy: a new horizon in diabetes management. J Diabetes Metabolic Disorders. 23(2):1665-86","DOI":"10.1007\/s40200-024-01479-3"},{"issue":"9","key":"11133_CR3","volume":"23","author":"J-H Lee","year":"2022","unstructured":"Lee J-H, Lee J (2022) Endoplasmic reticulum (ER) stress and its role in pancreatic \u03b2-cell dysfunction and senescence in type 2 diabetes. Int J Mol Sci 23(9):4843","journal-title":"Int J Mol Sci"},{"key":"11133_CR4","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.01607","volume":"10","author":"F Zatterale","year":"2020","unstructured":"Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C et al (2020) Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol 10:1607","journal-title":"Front Physiol"},{"issue":"2","key":"11133_CR5","first-page":"630","volume":"16","author":"Y Mortada","year":"2017","unstructured":"Mortada Y, Khojasteh K, Zarei M, Mansouri A, Jorjani M (2017) How nitric oxide increases in diabetic morphine tolerated male rats. Iran J Pharm Research: IJPR 16(2):630","journal-title":"Iran J Pharm Research: IJPR"},{"key":"11133_CR6","doi-asserted-by":"crossref","unstructured":"Zarei M, Sheikholeslami MA, Mozaffari M, Mortada Y (2024) Innovative immunotherapies and emerging treatments in type 1 diabetes management. Diabetes Epidemiol Manage. 17:100247","DOI":"10.1016\/j.deman.2024.100247"},{"issue":"2","key":"11133_CR7","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40200-024-01479-3","volume":"23","author":"M Zarei","year":"2024","unstructured":"Zarei M, Sahebi Vaighan N, Farjoo MH, Talebi S, Zarei M (2024) Incretin-based therapy: a new horizon in diabetes management. J Diabetes Metab Disord 23(2):1665\u20131686","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"11133_CR8","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13759","volume":"22","author":"K Miclau","year":"2023","unstructured":"Miclau K, Hambright WS, Huard J, Stoddart MJ, Bahney CS (2023) Cellular expansion of MSCs: shifting the regenerative potential. Aging Cell 22(1):e13759","journal-title":"Aging Cell"},{"issue":"1","key":"11133_CR9","volume":"15","author":"D Yan","year":"2024","unstructured":"Yan D, Song Y, Zhang B, Cao G, Zhou H, Li H et al (2024) Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications. Stem Cell Res Ther 15(1):3","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"11133_CR10","first-page":"43","volume":"10","author":"VK Singh","year":"2015","unstructured":"Singh VK, Kumar N, Kalsan M, Saini A, Chandra R (2015) Mechanism of induction: induced pluripotent stem cells (iPSCs). J Stem Cells 10(1):43","journal-title":"J Stem Cells"},{"issue":"30","key":"11133_CR11","doi-asserted-by":"crossref","first-page":"13426","DOI":"10.1073\/pnas.1007884107","volume":"107","author":"Z Alipio","year":"2010","unstructured":"Alipio Z, Liao W, Roemer EJ, Waner M, Fink LM, Ward DC et al (2010) Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic \u03b2-like cells. Proc Natl Acad Sci U S A 107(30):13426\u201313431","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11133_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179654","author":"F Arroyave","year":"2024","unstructured":"Arroyave F, Usc\u00e1tegui Y, Lizcano F (2024) From iPSCs to pancreatic \u03b2 cells: unveiling molecular pathways and enhancements with vitamin C and retinoic acid in diabetes research 25(17):9654. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25179654","journal-title":"Int J Mol Sci"},{"key":"11133_CR13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228685","volume":"21","author":"F Arroyave","year":"2020","unstructured":"Arroyave F, Monta\u00f1o D, Lizcano F (2020) Diabetes mellitus is a chronic disease that can benefit from therapy with induced pluripotent stem cells. Int J Mol Sci 21:22","journal-title":"Int J Mol Sci"},{"issue":"7","key":"11133_CR14","first-page":"e27337","volume":"14","author":"M Jayasinghe","year":"2022","unstructured":"Jayasinghe M, Prathiraja O, Perera PB, Jena R, Silva MS, Weerawarna PSH et al (2022) The role of mesenchymal stem cells in the treatment of type 1 diabetes. Cureus 14(7):e27337","journal-title":"Cureus"},{"issue":"6","key":"11133_CR15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI200316502","volume":"111","author":"A Ianus","year":"2003","unstructured":"Ianus A, Holz GG, Theise ND, Hussain MA (2003) In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111(6):843\u2013850","journal-title":"J Clin Invest"},{"issue":"1","key":"11133_CR16","volume":"8","author":"X Sun","year":"2017","unstructured":"Sun X, Hao H, Han Q, Song X, Liu J, Dong L et al (2017) Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther 8(1):241","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"11133_CR17","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2337\/db11-1141","volume":"61","author":"Y Si","year":"2012","unstructured":"Si Y, Zhao Y, Hao H, Liu J, Guo Y, Mu Y et al (2012) Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes 61(6):1616\u20131625","journal-title":"Diabetes"},{"key":"11133_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z (2019) Stem cells: past, present, and future. Stem Cell Res Ther 10:1\u201322","journal-title":"Stem Cell Res Ther"},{"issue":"01","key":"11133_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15419\/psc.v4i01.184","volume":"4","author":"NE Babiker","year":"2017","unstructured":"Babiker NE, Gassoum A, Abdelraheem NE, Arbab MA, ALDeaf SAH, El-Sheikh MAA et al (2017) The progress of stem cells in the treatment of diabetes mellitus type 1. Progress in Stem Cell 4(01):175\u2013188","journal-title":"Progress in Stem Cell"},{"key":"11133_CR20","unstructured":"Medicine, USNLo ClinicalTrials.gov. 2025"},{"issue":"10","key":"11133_CR21","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1089\/scd.2009.0164","volume":"18","author":"A Bhansali","year":"2009","unstructured":"Bhansali A, Upreti V, Khandelwal N, Marwaha N, Gupta V, Sachdeva N et al (2009) Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev 18(10):1407\u20131416","journal-title":"Stem Cells Dev"},{"issue":"3","key":"11133_CR22","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3892\/etm.2016.3544","volume":"12","author":"J Hu","year":"2016","unstructured":"Hu J, Wang Y, Gong H, Yu C, Guo C, Wang F et al (2016) Long term effect and safety of wharton\u2019s jelly-derived mesenchymal stem cells on type 2 diabetes. Exp Ther Med 12(3):1857\u20131866","journal-title":"Exp Ther Med"},{"issue":"6","key":"11133_CR23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/JLB.5MR0321-145R","volume":"110","author":"Y Wang","year":"2021","unstructured":"Wang Y, Qiu F, Xu Y, Hou X, Zhang Z, Huang L et al (2021) Stem cell-like memory T cells: the generation and application. J Leukoc Biol 110(6):1209\u20131223","journal-title":"J Leukoc Biol"},{"issue":"1","key":"11133_CR24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13098-025-01619-6","volume":"17","author":"M Kashbour","year":"2025","unstructured":"Kashbour M, Abdelmalik A, Yassin MNA, Abed M, Aldieb E, Abdullah DM et al (2025) Mesenchymal stem cell-based therapy for type 1 & 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials. Diabetol Metab Syndr 17(1):189","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"11133_CR25","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071054","volume":"12","author":"E Carulli","year":"2023","unstructured":"Carulli E, Pompilio G, Vinci MC (2023) Human hematopoietic stem\/progenitor cells in type one diabetes mellitus treatment: is there an ideal candidate? Cells 12(7):1054","journal-title":"Cells"},{"key":"11133_CR26","doi-asserted-by":"crossref","unstructured":"Yang N, Hickson LJ, Lerman LO (2024) Stem cell therapy for type-2 diabetes: keeping the pedal to the metal to deliver translation to the clinic. Taylor & Francis, pp 1183\u20131187","DOI":"10.1080\/14712598.2024.2422358"},{"key":"11133_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2018.07.009","volume":"160","author":"N Gurusamy","year":"2018","unstructured":"Gurusamy N, Alsayari A, Rajasingh S, Rajasingh J (2018) Adult stem cells for regenerative therapy. Prog Mol Biol Transl Sci 160:1\u201322","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"4","key":"11133_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8(4):315\u2013317","journal-title":"Cytotherapy"},{"key":"11133_CR29","volume":"15","author":"H Liu","year":"2021","unstructured":"Liu H, Reiter S, Zhou X, Chen H, Ou Y, Lenahan C et al (2021) Insight into the mechanisms and the challenges on stem cell-based therapies for cerebral ischemic stroke. Front Cell Neurosci 15:637210","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"11133_CR30","volume":"16","author":"J He","year":"2021","unstructured":"He J, Kong D, Yang Z, Guo R, Amponsah AE, Feng B et al (2021) Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: systematic review and meta-analysis of RCT data. PLoS ONE 16(3):e0247662","journal-title":"PLoS ONE"},{"issue":"1","key":"11133_CR31","volume":"2015","author":"F Ezquer","year":"2015","unstructured":"Ezquer F, Giraud-Billoud M, Carpio D, Cabezas F, Conget P, Ezquer M (2015) Proregenerative microenvironment triggered by donor mesenchymal stem cells preserves renal function and structure in mice with severe diabetes mellitus. Biomed Res Int 2015(1):164703","journal-title":"Biomed Res Int"},{"issue":"9","key":"11133_CR32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/sctm.20-0506","volume":"10","author":"LT Nguyen","year":"2021","unstructured":"Nguyen LT, Hoang DM, Nguyen KT, Bui DM, Nguyen HT, Le HT et al (2021) Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem\/stromal cells. Stem Cells Transl Med 10(9):1266\u20131278","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"11133_CR33","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3727\/096368908787648119","volume":"17","author":"EJ Estrada","year":"2008","unstructured":"Estrada EJ, Valacchi F, Nicora E, Brieva S, Esteve C, Echevarria L et al (2008) Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus. Cell Transplant 17(12):1295\u20131304","journal-title":"Cell Transplant"},{"key":"11133_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10110471","author":"F Lizcano","year":"2020","unstructured":"Lizcano F, Arroyave F (2020) Control of adipose cell browning and its therapeutic potential. Metabolites 10(11):471 https:\/\/doi.org\/10.3390\/metabo10110471","journal-title":"Metabolites"},{"key":"11133_CR35","doi-asserted-by":"crossref","DOI":"10.1016\/j.deman.2024.100247","volume":"17","author":"M Zarei","year":"2025","unstructured":"Zarei M, Sheikholeslami MA, Mozaffari M, Mortada Y (2025) Innovative immunotherapies and emerging treatments in type 1 diabetes management. Diabetes Epidemiology and Management 17:100247","journal-title":"Diabetes Epidemiology and Management"},{"issue":"9","key":"11133_CR36","volume":"3","author":"GC Weir","year":"2011","unstructured":"Weir GC, Cavelti-Weder C, Bonner-Weir S (2011) Stem cell approaches for diabetes: towards beta cell replacement. Genome Med 3(9):61","journal-title":"Genome Med"},{"issue":"1","key":"11133_CR37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.15419\/bmrat.v4i1.144","volume":"4","author":"LT-T Dang","year":"2017","unstructured":"Dang LT-T, Phan NK, Truong KD (2017) Mesenchymal stem cells for diabetes mellitus treatment: new advances. Biomed Res Ther 4(1):1062\u20131081","journal-title":"Biomed Res Ther"},{"issue":"2","key":"11133_CR38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca FW, Millman JR, G\u00fcrtler M, Segel M, Van Dervort A, Ryu JH et al (2014) Generation of functional human pancreatic \u03b2 cells in vitro. Cell 159(2):428\u2013439","journal-title":"Cell"},{"issue":"3","key":"11133_CR39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/kisup.2011.22","volume":"1","author":"JC Voltarelli","year":"2011","unstructured":"Voltarelli JC, Couri CE, Oliveira MC, Moraes DA, Stracieri AB, Pieroni F (2011) Stem cell therapy for diabetes mellitus. Kidney Int Suppl 1(3):94\u201398","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"11133_CR40","first-page":"9938658","volume":"2021","author":"Q Huang","year":"2021","unstructured":"Huang Q, Huang Y, Liu J (2021) Mesenchymal stem cells: an excellent candidate for the treatment of diabetes mellitus. Int J Endocrinol 2021(1):9938658","journal-title":"Int J Endocrinol"},{"issue":"9","key":"11133_CR41","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3727\/096368913X665576","volume":"23","author":"A Bhansali","year":"2014","unstructured":"Bhansali A, Asokumar P, Walia R, Bhansali S, Gupta V, Jain A et al (2014) Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: a randomized placebo-controlled study. Cell Transplant 23(9):1075\u20131085","journal-title":"Cell Transplant"},{"issue":"2","key":"11133_CR42","volume":"5","author":"X Liu","year":"2014","unstructured":"Liu X, Zheng P, Wang X, Dai G, Cheng H, Zhang Z et al (2014) A preliminary evaluation of efficacy and safety of wharton\u2019s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cell Res Ther 5(2):57","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"11133_CR43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11684-011-0116-z","volume":"5","author":"R Jiang","year":"2011","unstructured":"Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X et al (2011) Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med 5(1):94\u2013100","journal-title":"Front Med"},{"issue":"7","key":"11133_CR44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/scd.2016.0275","volume":"26","author":"S Bhansali","year":"2017","unstructured":"Bhansali S, Dutta P, Kumar V, Yadav MK, Jain A, Mudaliar S et al (2017) Efficacy of autologous bone marrow-derived mesenchymal stem cell and mononuclear cell transplantation in type 2 diabetes mellitus: a randomized, placebo-controlled comparative study. Stem Cells Dev 26(7):471\u2013481","journal-title":"Stem Cells Dev"},{"key":"11133_CR45","doi-asserted-by":"crossref","unstructured":"Weiss JN (2022) Efficacy and safety of umbilical cord mesenchymal stem cell transplantation in patients with type 2 diabetes Mellitus. stem cell surgery trials. Heart failure and diabetes: A concise guide. Springer International Publishing, Cham, pp 163\u2013165","DOI":"10.1007\/978-3-030-78010-4_31"},{"issue":"10","key":"11133_CR46","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1681\/ASN.0000000000000189","volume":"34","author":"N Perico","year":"2023","unstructured":"Perico N, Remuzzi G, Griffin MD, Cockwell P, Maxwell AP, Casiraghi F et al (2023) Safety and preliminary efficacy of mesenchymal stromal cell (ORBCEL-M) therapy in diabetic kidney disease: a randomized clinical trial (NEPHSTROM). J Am Soc Nephrol 34(10):1733\u20131751","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"11133_CR47","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S1465-3249(23)00234-7","volume":"25","author":"K Elhusseiny","year":"2023","unstructured":"Elhusseiny K, Alatta L, Snow Z, Skaff C, Aslam N, Porter I (2023) Mesenchymal stem\/Stromal cells: mesenchymal stem cell therapy in diabetic kidney disease: evaluating safety and response predictors. Cytotherapy 25(6):S61\u2013S2","journal-title":"Cytotherapy"},{"key":"11133_CR48","volume":"14","author":"X Yu","year":"2023","unstructured":"Yu X, Liu P, Li Z, Zhang Z (2023) Function and mechanism of mesenchymal stem cells in the healing of diabetic foot wounds. Front Endocrinol 14:1099310","journal-title":"Front Endocrinol"},{"issue":"1","key":"11133_CR49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1167\/iovs.08-1748","volume":"50","author":"S Brunner","year":"2009","unstructured":"Brunner S, Schernthaner G-H, Satler M, Elhenicky M, Hoellerl F, Schmid-Kubista KE et al (2009) Correlation of different Circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. Investig Ophthalmol Vis Sci 50(1):392\u2013398","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"11133_CR50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.exer.2007.04.007","volume":"85","author":"Y Inoue","year":"2007","unstructured":"Inoue Y, Iriyama A, Ueno S, Takahashi H, Kondo M, Tamaki Y et al (2007) Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res 85(2):234\u2013241","journal-title":"Exp Eye Res"},{"issue":"3","key":"11133_CR51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcyt.2012.11.002","volume":"15","author":"S Mottaghi","year":"2013","unstructured":"Mottaghi S, Larijani B, Sharifi AM (2013) Atorvastatin: an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy. Cytotherapy 15(3):263\u2013266","journal-title":"Cytotherapy"},{"issue":"2","key":"11133_CR52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/oxim.3.2.11148","volume":"3","author":"S-i Yamagishi","year":"2010","unstructured":"Yamagishi S-i, Matsui T (2010) Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev 3(2):101\u2013108","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"11133_CR53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.pathol.4.110807.092150","volume":"6","author":"YS Kanwar","year":"2011","unstructured":"Kanwar YS, Sun L, Xie P, Liu F-y, Chen S (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6(1):395\u2013423","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"11133_CR54","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1681\/ASN.2007020140","volume":"18","author":"B Bi","year":"2007","unstructured":"Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG (2007) Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18(9):2486\u20132496","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"11133_CR55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000363239","volume":"78","author":"HG Pala","year":"2014","unstructured":"Pala HG, Pala EE, Artunc Ulkumen B, Aktug H, Yavasoglu A, Korkmaz HA et al (2014) The protective effect of granulocyte colony-stimulating factor on endometrium and ovary in a rat model of diabetes mellitus. Gynecol Obstet Invest 78(2):94\u2013100","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"11133_CR56","doi-asserted-by":"crossref","DOI":"10.1038\/srep34842","volume":"6","author":"K Nagaishi","year":"2016","unstructured":"Nagaishi K, Mizue Y, Chikenji T, Otani M, Nakano M, Konari N et al (2016) Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep 6(1):34842","journal-title":"Sci Rep"},{"issue":"7","key":"11133_CR57","doi-asserted-by":"crossref","DOI":"10.1590\/acb370704","volume":"37","author":"MF Bozkurt","year":"2022","unstructured":"Bozkurt MF, Bhaya MN, Dibeko\u011flu C, Akat A, Ate\u015f U, Erba\u015f O (2022) Mesenchymal stem cells have ameliorative effect on the colitis model via Nrf2\/HO-1 pathway. Acta Cir Bras 37(7):e370704","journal-title":"Acta Cir Bras"},{"issue":"9","key":"11133_CR58","volume":"7","author":"B Song","year":"2012","unstructured":"Song B, Smink AM, Jones CV, Callaghan JM, Firth SD, Bernard CA et al (2012) The directed differentiation of human iPS cells into kidney podocytes. PLoS ONE 7(9):e46453","journal-title":"PLoS ONE"},{"issue":"6","key":"11133_CR59","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1681\/ASN.2013080831","volume":"25","author":"AQ Lam","year":"2014","unstructured":"Lam AQ, Freedman BS, Morizane R, Lerou PH, Valerius MT, Bonventre JV (2014) Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol 25(6):1211\u20131225","journal-title":"J Am Soc Nephrol"},{"issue":"11\u201312","key":"11133_CR60","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1159\/000517364","volume":"105","author":"S Al Demour","year":"2021","unstructured":"Al Demour S, Adwan S, Jafar H, Rahmeh R, Alhawari H, Awidi A (2021) Safety and efficacy of 2 intracavernous injections of allogeneic wharton\u2019s jelly-derived mesenchymal stem cells in diabetic patients with erectile dysfunction: phase 1\/2 clinical trial. Urol Int 105(11\u201312):935\u2013943","journal-title":"Urol Int"},{"key":"11133_CR61","doi-asserted-by":"crossref","unstructured":"Scalinci SZ, Scorolli L, Corradetti G, Domanico D, Vingolo EM, Meduri A et al (2011) Potential role of intravitreal human placental stem cell implants in inhibiting progression of diabetic retinopathy in type 2 diabetes: neuroprotective growth factors in the vitreous. Clin Ophthalmol 5:691\u2013696 Clinical ophthalmology (Auckland, NZ)","DOI":"10.2147\/OPTH.S21161"},{"issue":"2","key":"11133_CR62","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1111\/aos.12473","volume":"93","author":"RC Siqueira","year":"2015","unstructured":"Siqueira RC, Messias A, Gurgel VP, Sim\u00f5es BP, Scott IU, Jorge R (2015) Improvement of ischaemic macular oedema after intravitreal injection of autologous bone marrow-derived haematopoietic stem cells. Acta Ophthalmol 93(2):e174\u2013e176","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"11133_CR63","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm0602-607","volume":"8","author":"MB Grant","year":"2002","unstructured":"Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, Mames RN et al (2002) Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8(6):607\u2013612","journal-title":"Nat Med"},{"issue":"12","key":"11133_CR64","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1172\/JCI29683","volume":"116","author":"MR Ritter","year":"2006","unstructured":"Ritter MR, Banin E, Moreno SK, Aguilar E, Dorrell MI, Friedlander M (2006) Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest 116(12):3266\u20133276","journal-title":"J Clin Invest"},{"issue":"2","key":"11133_CR65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4093\/dmj.2013.37.2.91","volume":"37","author":"JW Han","year":"2013","unstructured":"Han JW, Sin MY, Yoon YS (2013) Cell therapy for diabetic neuropathy using adult stem or progenitor cells. Diabetes Metab J 37(2):91\u2013105","journal-title":"Diabetes Metab J"},{"issue":"10","key":"11133_CR66","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1177\/1933719118816839","volume":"26","author":"I Hortu","year":"2019","unstructured":"Hortu I, Ozceltik G, Sahin C, Akman L, Yildirim N, Erbas O (2019) Granulocyte colony-stimulating factor prevents ischemia\/reperfusion-induced ovarian injury in rats: evaluation of histological and biochemical parameters. Reprod Sci 26(10):1389\u20131394","journal-title":"Reprod Sci"},{"key":"11133_CR67","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/164703","volume":"2015","author":"F Ezquer","year":"2015","unstructured":"Ezquer F, Giraud-Billoud M, Carpio D, Cabezas F, Conget P, Ezquer M (2015) Proregenerative microenvironment triggered by donor mesenchymal stem cells preserves renal function and structure in mice with severe diabetes mellitus. Biomed Res Int 2015:164703","journal-title":"Biomed Res Int"},{"key":"11133_CR68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2147\/DMSO.S392161","volume":"16","author":"A Mathur","year":"2023","unstructured":"Mathur A, Taurin S, Alshammary S (2023) The safety and efficacy of mesenchymal stem cells in the treatment of type 2 Diabetes- a literature review. Diabetes Metab Syndr Obes 16:769\u2013777","journal-title":"Diabetes Metab Syndr Obes"},{"key":"11133_CR69","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S392161","author":"A Mathur","year":"2023","unstructured":"Mathur A, Taurin S, Alshammary S (2023) The safety and efficacy of mesenchymal stem cells in the treatment of type 2 diabetes-a literature review. Diabetes Metab Syndr Obes16:769-77 https:\/\/doi.org\/10.2147\/DMSO.S392161","journal-title":"Diabetes Metab Syndr Obes"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11133-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11133-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11133-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:06:19Z","timestamp":1766898379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11133-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11133"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11133-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}}],"article-number":"1046"}}